Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Interleukin 10: a new risk marker for the development of restenosis after percutaneous coronary intervention.

Monraats PS, Kurreeman FA, Pons D, Sewgobind VD, de Vries FR, Zwinderman AH, de Maat MP, Doevendans PA, de Winter RJ, Tio RA, Waltenberger J, Huizinga TW, Eefting D, Quax PH, Frants RR, van der Laarse A, van der Wall EE, Jukema JW.

Genes Immun. 2007 Jan;8(1):44-50. Epub 2006 Nov 23.

PMID:
17122782
2.

Inflammation and apoptosis genes and the risk of restenosis after percutaneous coronary intervention.

Monraats PS, de Vries F, de Jong LW, Pons D, Sewgobind VD, Zwinderman AH, de Maat MP, 't Hart LM, Doevendans PA, de Winter RJ, Tio RA, Waltenberger J, Frants RR, van der Laarse A, van der Wall EE, Wouter Jukema J.

Pharmacogenet Genomics. 2006 Oct;16(10):747-54.

PMID:
17001294
3.

The influence of established genetic variation in the haemostatic system on clinical restenosis after percutaneous coronary interventions.

Pons D, Monraats PS, de Maat MP, Pires NM, Quax PH, van Vlijmen BJ, Rosendaal FR, Zwinderman AH, Doevendans PA, Waltenberger J, de Winter RJ, Tio RA, Frants RR, van der Laarse A, van der Wall EE, Jukema JW.

Thromb Haemost. 2007 Dec;98(6):1323-8.

PMID:
18064331
4.

Genetic inflammatory factors predict restenosis after percutaneous coronary interventions.

Monraats PS, Pires NM, Agema WR, Zwinderman AH, Schepers A, de Maat MP, Doevendans PA, de Winter RJ, Tio RA, Waltenberger J, Frants RR, Quax PH, van Vlijmen BJ, Atsma DE, van der Laarse A, van der Wall EE, Jukema JW.

Circulation. 2005 Oct 18;112(16):2417-25.

5.

Lipoprotein lipase gene polymorphisms and the risk of target vessel revascularization after percutaneous coronary intervention.

Monraats PS, Rana JS, Nierman MC, Pires NM, Zwinderman AH, Kastelein JJ, Kuivenhoven JA, de Maat MP, Rittersma SZ, Schepers A, Doevendans PA, de Winter RJ, Tio RA, Frants RR, Quax PH, van der Laarse A, van der Wall EE, Jukema JW.

J Am Coll Cardiol. 2005 Sep 20;46(6):1093-100.

6.

Clinical restenosis after coronary stent implantation is associated with the heme oxygenase-1 gene promoter polymorphism and the heme oxygenase-1 +99G/C variant.

Gulesserian T, Wenzel C, Endler G, Sunder-Plassmann R, Marsik C, Mannhalter C, Iordanova N, Gyöngyösi M, Wojta J, Mustafa S, Wagner O, Huber K.

Clin Chem. 2005 Sep;51(9):1661-5. Epub 2005 Jul 14.

7.

Tumor necrosis factor-alpha, lymphotoxin-alpha, and interleukin-10 gene polymorphisms and restenosis after coronary artery stenting.

Koch W, Tiroch K, von Beckerath N, Schömig A, Kastrati A.

Cytokine. 2003 Nov 21;24(4):161-71.

PMID:
14572794
8.

The interleukin 1B-511 polymorphism is associated with the risk of developing restenosis after coronary stenting in Mexican patients.

Miranda-Malpica E, Martínez-Rios MA, Fragoso JM, Delgadillo-Rodríguez H, Rodríguez-Pérez JM, González-Quesada C, Martínez-Rodríguez N, Saldaña-Mendoza A, Peña-Duque MA, Vargas-Alarcón G.

Hum Immunol. 2008 Feb;69(2):116-21. doi: 10.1016/j.humimm.2007.12.003. Epub 2008 Jan 22.

PMID:
18361937
9.

Restenosis after percutaneous coronary intervention is associated with the angiotensin-II type-1 receptor 1166A/C polymorphism but not with polymorphisms of angiotensin-converting enzyme, angiotensin-II receptor, angiotensinogen or heme oxygenase-1.

Wijpkema JS, van Haelst PL, Monraats PS, Bruinenberg M, Zwinderman AH, Zijlstra F, van der Steege G, de Winter RJ, Doevendans PA, Waltenberger J, Jukema JW, Tio RA.

Pharmacogenet Genomics. 2006 May;16(5):331-7.

PMID:
16609364
10.

The -374T/A variant of the rage gene promoter is associated with clinical restenosis after coronary stent placement.

Falcone C, Emanuele E, Buzzi MP, Ballerini L, Repetto A, Canosi U, Mazzucchelli I, Schirinzi S, Sbarsi I, Boiocchi C, Cuccia M.

Int J Immunopathol Pharmacol. 2007 Oct-Dec;20(4):771-7.

PMID:
18179750
11.

Candidate genetic markers and the risk of restenosis after coronary angioplasty.

Völzke H, Grimm R, Robinson DM, Wolff B, Schwahn C, Hertwig S, Motz W, Rettig R.

Clin Sci (Lond). 2004 Jan;106(1):35-42.

PMID:
12899665
12.

The microsatellite polymorphism of heme oxygenase-1 is associated with baseline plasma IL-6 level but not with restenosis after coronary in-stenting.

Li P, Elrayess MA, Gomma AH, Palmen J, Hawe E, Fox KM, Humphries SE.

Chin Med J (Engl). 2005 Sep 20;118(18):1525-32.

PMID:
16232329
13.

Tumor necrosis factor alpha and interleukin 10 promoter polymorphisms in Mexican patients with restenosis after coronary stenting.

Martínez-Ríos MA, Peña-Duque MA, Fragoso JM, Delgadillo-Rodríguez H, Rodríguez-Pérez JM, Miranda-Malpica E, Cruz-Robles D, Cavazos-Quero MM, Rodríguez-Lobato LG, Vargas-Alarcón G.

Biochem Genet. 2009 Oct;47(9-10):707-16. doi: 10.1007/s10528-009-9268-9. Epub 2009 Jul 8.

PMID:
19585232
14.

Platelet receptor P2RY12 haplotypes predict restenosis after percutaneous coronary interventions.

Rudez G, Pons D, Leebeek F, Monraats P, Schrevel M, Zwinderman A, de Winter R, Tio R, Doevendans P, Jukema W, de Maat M.

Hum Mutat. 2008 Mar;29(3):375-80. doi: 10.1002/humu.20641.

PMID:
18175333
15.

Metabolic syndrome and risk of restenosis in patients undergoing percutaneous coronary intervention.

Rana JS, Monraats PS, Zwinderman AH, de Maat MP, Kastelein JJ, Doevendans PA, de Winter RJ, Tio RA, Frants RR, van der Laarse A, van der Wall EE, Jukema JW; GENDER study.

Diabetes Care. 2005 Apr;28(4):873-7.

PMID:
15793188
16.

p27kip1-838C>A single nucleotide polymorphism is associated with restenosis risk after coronary stenting and modulates p27kip1 promoter activity.

van Tiel CM, Bonta PI, Rittersma SZ, Beijk MA, Bradley EJ, Klous AM, Koch KT, Baas F, Jukema JW, Pons D, Sampietro ML, Pannekoek H, de Winter RJ, de Vries CJ.

Circulation. 2009 Aug 25;120(8):669-76. doi: 10.1161/CIRCULATIONAHA.108.842179. Epub 2009 Aug 10.

17.

Interleukin 8 gene polymorphisms and susceptibility to restenosis after percutaneous coronary intervention.

Vogiatzi K, Apostolakis S, Voudris V, Thomopoulou S, Kochiadakis GE, Spandidos DA.

J Thromb Thrombolysis. 2010 Jan;29(1):134-40. doi: 10.1007/s11239-009-0338-y.

PMID:
19404719
18.

Are common leptin promoter polymorphisms associated with restenosis after coronary stenting?

Bienertová-Vasků JA, Hlinomaz O, Vasků A.

Heart Vessels. 2007 Sep;22(5):310-5. Epub 2007 Sep 20.

PMID:
17879022
19.

Relationship of interleukin-6-572C/G promoter polymorphism and serum levels to post-percutaneous coronary intervention restenosis.

Gao J, Liu Y, Cui RZ, Mao YM, Zhou J, Chen Q, Zhao FM, Yang GM.

Chin Med J (Engl). 2013 Mar;126(6):1019-25.

20.

[Relationship of interleukin-10 gene polymorphism with restenosis after percutaneous coronary intervention in Chinese].

Gao J, Cui RZ, Liu Y, Mao YM, Zhou J, Chen Q, Zhao FM, Yang GM, Liu T.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2011 Feb;28(1):42-6. doi: 10.3760/cma.j.issn.1003-9406.2011.01.010. Chinese.

PMID:
21287508
Items per page

Supplemental Content

Write to the Help Desk